Integration of the Hamilton Microlab Star within HtL at AstraZeneca R&D Charnwood
News Jun 06, 2007
AstraZeneca requires automation of multiple applications across different processes. The use of the flexible and modular Microlab® Star enables AstraZeneca to use one instrument for diverse applications ranging from compound dilution to assay construction.
Working closely with AstraZeneca, Hamilton have designed a system that has greater capacity and functionality than AstraZeneca’s previous machines, enabling them to carry out accurate dilutions.
The Microlab STAR’s features like “Dual Liquid Level Detection”, “Monitored Air Dipslacement” and the CO-RE technology have increased the process safety remarkably at AstraZeneca.
The Hamilton Software has been incorporated into the in-house sample management system, which has enabled full sample/data tracking and an increase in the speed of sample processing.
The Microlab STAR system shows a decrease in assay variability and an increase in throughput and accuracy. As a result the Microlab STAR has become the benchmark instrument within HtL at AstraZeneca R&D Charnwood.
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018